Israeli fintech Balance, health-tech firm Antidote get early-stage funding

 Israeli fintech Balance, health-tech firm Antidote get early-stage funding

Israeli fintech company Balance has raised $25 million in a Series A funding round led by Ribbit Capital.

Ribbit Capital was joined by women-led fund Avid Ventures and by existing investors including Stripe, Lightspeed, Y Combinator, Upwest and Scifi VC.

Apart from these investors, current and former employees at Plaid, Square, PayPal, Stripe, Brex and Coinbase also pitched in.

The lead investor for this round, Ribbit Capital, has previously backed marquee companies such as Coinbase and Robinhood as well as Israel-based Next Insurance.

Balance was founded in 2020 by two former Paypal employees, chief executive officer Bar Geron and vice-president of development Yoni Shuster. It had earlier raised $5.5 million in a seed funding round.

The startup employs 25 people, most of whom are based in Israel.

Antidote Health

Antidote Health, an Israeli telehealth company that launched in January, has raised $12 million in a seed financing round.

The seed round was led by iAngels, Well-Tech Ventures and Flint Capital. A bunch of individual angel investors also participated in the funding round.

The Israeli startup provides Americans who are under-insured or uninsured with a virtual health maintenance organisation using an artificial intelligence-based solution that connects patients with doctors via video calls and chatbots.

Antidote Health was founded by chief executive officer Avihai Sodri, chief technology officer Carine-Belle Feder, chief medical officer David Zlotnik, and chairman and president Ben Enosh.

Enosh had earlier co-founded Cyota, with the current Israeli prime minister Naftali Bennett, Michal Tzur and Lior Golan.

Aman Malik

The Capital Quest